Alto Neuroscience (ANRO) is down -62.8%, or -$9.13 to $5.40.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANRO:
- Morning Movers: AT&T rises and Coca-Cola falls following quarterly reports
- Wedbush downgrades Alto Neuroscience to Neutral following ALTO-100 readout
- Alto Neuroscience downgraded to Neutral from Outperform at Wedbush
- Alto Neuroscience downgraded to Neutral from Buy at Rodman & Renshaw
- Alto Neuroscience price target lowered to $10 from $32 at Baird